Loading…

NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases

Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology 2017-04, Vol.8, p.399-399
Main Authors: Aksentijevich, Ivona, Zhou, Qing
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3
cites cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3
container_end_page 399
container_issue
container_start_page 399
container_title Frontiers in immunology
container_volume 8
creator Aksentijevich, Ivona
Zhou, Qing
description Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.
doi_str_mv 10.3389/fimmu.2017.00399
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085</doaj_id><sourcerecordid>1895275210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</originalsourceid><addsrcrecordid>eNp1ks1O3DAUhaOqVUGUfVeVl91k8E_sxF1UojOlRaKURVlbjn09GCUxxA4o79Gn4SH6TPXMUASLemFb597zXUs-RfGe4AVjjTxyvu-nBcWkXmDMpHxV7BMhqpJRWr1-dt8rDmO8xnlVkjHG3xZ7tKmEFBTvF7_PT8o_D1_QhU5X93pGfkDHUwp-cJ3ue53COKOVj6AjxE9oNccR1lOnkw8DCg5djCFB9vwI1jtvtnpE7YwuW387-ZRLK3B-gIg0Ood7tNQJ1htoNv930LvijdNdhMPH86C4PPn6a_m9PPv57XR5fFaaStBUEuew0U42stGVpdhIaDGpTN4Bg-GOWMpqEA1voNZOO6pb5irAPPc0lWUHxemOa4O-Vjej7_U4q6C92gphXCs9Jm86UIZwyWsrBBG2sty0jtY2a7V1WOCGZ9bnHetmanuwBoY06u4F9GVl8FdqHe4UZ5ILuQF8fASM4XaCmFTvo4Gu0wOEKSrSSE5rTgnOrXjXasYQ84-4pzEEq0021DYbapMNtc1Gtnx4_rwnw78ksL-rWrsl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1895275210</pqid></control><display><type>article</type><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><source>PubMed Central</source><creator>Aksentijevich, Ivona ; Zhou, Qing</creator><creatorcontrib>Aksentijevich, Ivona ; Zhou, Qing</creatorcontrib><description>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2017.00399</identifier><identifier>PMID: 28469620</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>haploinsufficiency of A20 ; Immunology ; linear ubiquitin chain assembly complex ; LUBAC deficiency ; OTULIN ; otulipenia/otulin-related autoinflammatory syndrome ; TNFAIP3/A20</subject><ispartof>Frontiers in immunology, 2017-04, Vol.8, p.399-399</ispartof><rights>Copyright © 2017 Aksentijevich and Zhou. 2017 Aksentijevich and Zhou</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</citedby><cites>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395695/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395695/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28469620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aksentijevich, Ivona</creatorcontrib><creatorcontrib>Zhou, Qing</creatorcontrib><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</description><subject>haploinsufficiency of A20</subject><subject>Immunology</subject><subject>linear ubiquitin chain assembly complex</subject><subject>LUBAC deficiency</subject><subject>OTULIN</subject><subject>otulipenia/otulin-related autoinflammatory syndrome</subject><subject>TNFAIP3/A20</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp1ks1O3DAUhaOqVUGUfVeVl91k8E_sxF1UojOlRaKURVlbjn09GCUxxA4o79Gn4SH6TPXMUASLemFb597zXUs-RfGe4AVjjTxyvu-nBcWkXmDMpHxV7BMhqpJRWr1-dt8rDmO8xnlVkjHG3xZ7tKmEFBTvF7_PT8o_D1_QhU5X93pGfkDHUwp-cJ3ue53COKOVj6AjxE9oNccR1lOnkw8DCg5djCFB9vwI1jtvtnpE7YwuW387-ZRLK3B-gIg0Ood7tNQJ1htoNv930LvijdNdhMPH86C4PPn6a_m9PPv57XR5fFaaStBUEuew0U42stGVpdhIaDGpTN4Bg-GOWMpqEA1voNZOO6pb5irAPPc0lWUHxemOa4O-Vjej7_U4q6C92gphXCs9Jm86UIZwyWsrBBG2sty0jtY2a7V1WOCGZ9bnHetmanuwBoY06u4F9GVl8FdqHe4UZ5ILuQF8fASM4XaCmFTvo4Gu0wOEKSrSSE5rTgnOrXjXasYQ84-4pzEEq0021DYbapMNtc1Gtnx4_rwnw78ksL-rWrsl</recordid><startdate>20170419</startdate><enddate>20170419</enddate><creator>Aksentijevich, Ivona</creator><creator>Zhou, Qing</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170419</creationdate><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><author>Aksentijevich, Ivona ; Zhou, Qing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>haploinsufficiency of A20</topic><topic>Immunology</topic><topic>linear ubiquitin chain assembly complex</topic><topic>LUBAC deficiency</topic><topic>OTULIN</topic><topic>otulipenia/otulin-related autoinflammatory syndrome</topic><topic>TNFAIP3/A20</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aksentijevich, Ivona</creatorcontrib><creatorcontrib>Zhou, Qing</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aksentijevich, Ivona</au><au>Zhou, Qing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2017-04-19</date><risdate>2017</risdate><volume>8</volume><spage>399</spage><epage>399</epage><pages>399-399</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28469620</pmid><doi>10.3389/fimmu.2017.00399</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-3224
ispartof Frontiers in immunology, 2017-04, Vol.8, p.399-399
issn 1664-3224
1664-3224
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085
source PubMed Central
subjects haploinsufficiency of A20
Immunology
linear ubiquitin chain assembly complex
LUBAC deficiency
OTULIN
otulipenia/otulin-related autoinflammatory syndrome
TNFAIP3/A20
title NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NF-%CE%BAB%20Pathway%20in%20Autoinflammatory%20Diseases:%20Dysregulation%20of%20Protein%20Modifications%20by%20Ubiquitin%20Defines%20a%20New%20Category%20of%20Autoinflammatory%20Diseases&rft.jtitle=Frontiers%20in%20immunology&rft.au=Aksentijevich,%20Ivona&rft.date=2017-04-19&rft.volume=8&rft.spage=399&rft.epage=399&rft.pages=399-399&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2017.00399&rft_dat=%3Cproquest_doaj_%3E1895275210%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1895275210&rft_id=info:pmid/28469620&rfr_iscdi=true